NOT KNOWN FACTUAL STATEMENTS ABOUT PHENOBARBITAL SODIUM DRUG CLASS

pentobarbital will lessen the extent or effect of brexpiprazole by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Carefully. Double brexpiprazole dose over one-2 weeks if administered with a robust CYP3A4 inducer.pentobarbital will minimize the extent or effect of oxybutynin by impacting hepatic/intestinal enzyme CY